Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
Delayed Quote. Delayed Nyse - 09/24 04:10:00 pm
73.61 USD   +0.77%
09/24Health Care Stocks Retreat Friday
MT
09/24Wall Street Tumbles Pre-Bell, Evergrande Risks Resurface
MT
09/24Health Care Stocks Slip Pre-Bell Friday
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
09/24Health Care Stocks Retreat Friday
MT
09/24Wall Street Tumbles Pre-Bell, Evergrande Risks Resurface
MT
09/24Health Care Stocks Slip Pre-Bell Friday
MT
09/24MERCK : LYNPARZA« (olaparib) in Combination With Abiraterone Significantly Delayed Disease..
BU
09/24AstraZeneca and Merck Announce Positive Results from the Phase 3 PROpel Trial
CI
09/24ASTRAZENECA : Merck & Co.'s Combination Therapy Benefits Prostate Cancer Patients in Phase..
MT
09/24ASTRAZENECA : Merck & Co.'s Prostate Cancer Drug Extends Lives in Late-Stage Study
MT
09/21MERCK : Thinking about trading options or stock in Draftkings, Merck, ConocoPhillips, Walg..
PR
09/21MERCK : Building Sustainable Value for our Business and Society
PU
09/20MERCK : KEYTRUDA (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Ris..
AQ
09/20MERCK : KEYTRUDA (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Che..
AQ
09/20MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) in Combination With..
AQ
09/20MERCK : KEYTRUDA (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in P..
AQ
09/19MERCK : KEYTRUDA« (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Ch..
BU
09/19Merck’s Keytruda« Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as..
CI
09/18MERCK : KEYTRUDA« (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Ri..
BU
09/18MERCK : KEYTRUDA« (pembrolizumab) Demonstrated Superior Recurrence-Free Survival (RFS) in ..
BU
09/18Merck Announces the First Results from the Phase 3 Keynote-716 Trial
CI
09/17Preview -- Barron's
DJ
09/17MERCK : Receives Positive Opinion for Keytruda, Chemotherapy Combination From European Reg..
MT
09/17MERCK : Receives Positive EU CHMP Opinion for KEYTRUDA« (pembrolizumab) in Combination Wit..
BU
09/17Merck Receives Positive EU CHMP Opinion for KEYTRUDA« (Pembrolizumab) in Combination wi..
CI
09/17Merck Gets CHMP Backing of Keytruda in Triple-Negative Breast Cancer
DJ
09/17MERCK : EquiTrace wins Best Start-Up Award & new Best Vet Tech Award at the Innovation Are..
AQ
09/16SILVERBACK THERAPEUTICS : Reports Early Data From Phase 1/1b Study of SBT6050 in Solid Tum..
MT
09/16HOOKIPA PHARMA : announces clinical collaboration with Merck & Co., Inc., Kenilworth, NJ.,..
AQ
09/16BIOXCEL THERAPEUTICS : Says Therapeutics Study Shows Anti-Tumor Activity of Prostate Cance..
MT
09/16BIOCORP and MERCK Sign a Partnership in the Field of Human Growth Hormone
CI
09/15HOOKIPA PHARMA : Merck Collaborate on Head, Neck Cancer Combo Therapy Development
MT
09/15HOOKIPA Pharma Inc. Announces Clinical Collaboration with Merck & Co., Inc., Kenilworth..
CI
09/15Hookipa Working With Merck in Advanced Head and Neck Cancers
DJ
09/14IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTR..
CI
09/14MERCK & CO., INC. : Ex-dividend day for
FA
09/13Merck sees potential U.S. authorization for COVID-19 antiviral before year-end
RE
09/13MERCK & C : mpany CEO Expects Clinical Data on Covid Vaccine in H2 2021, Possible EUA Befo..
MT
09/13MERCK : Cooley Continues Life Sciences Partnering Growth On East Coast
AQ
09/09Codexis, Inc. and Merck Amend and Extend License and Supply Agreement for Enzyme Used i..
CI
09/09U.S. government to tackle Medicare drug payments to try to cut costs
RE
09/09PDS BIOTECHNOLOGY : Completes Recruitment in Safety Cohort of Phase 2 Study of HPV-Associa..
MT
09/08MERCK : Berenberg Bank Adjusts Merck & Company PT to $86 From $88, Maintains Hold Rating
MT
09/08MERCK : To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, I..
BU
09/08Merck To Present New Data From Its Broad Oncology Portfolio and Pipeline at ESMO 2021, ..
CI
09/07Illumina, Merck to Collaborate Over Diagnostic Tests For Cancer Mutations
MT
09/07MERCK : Morgan Stanley Downgrades Merck & Company to Equalweight from Overweight, Adjusts ..
MT
09/07Today on Wall Street: Back to business
09/07ANALYST RECOMMENDATIONS : Amgen, Banner, Merck, Oracle, Phoenix...
09/07MERCK : Says Keytruda is Now Approved for Additional Indication of Carcinoma in China
MT
09/07MERCK : to Present at the Morgan Stanley 19th Annual Healthcare Conference
BU
09/07MERCK : KEYTRUDA« (pembrolizumab) Approved in China in Combination With Chemotherapy for F..
BU
09/07Merck’s Keytruda (Pembrolizumab) Approves in China in Combination with Chemotherapy for..
CI
09/01GLOBAL MARKETS LIVE : Getlink, Intuit, CrowdStrike, Xiaomi, Merck...
09/01IMMUTEP : Completes Patient Enrollment in Stage 2 of Part B of NSCLC Study; Shares Drop Ea..
MT
09/01MERCK : Ridgeback Biotherapeutics Launch Phase 3 Trial of Potential COVID-19 Antiviral Mol..
MT
09/01MERCK : and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD St..
BU
09/01Merck and Ridgeback Biotherapeutics Announce Initiation of Pivotal Phase 3 MOVe-AHEAD S..
CI
09/01Merck, Ridgeback Launch Phase 3 Trial of Covid-19 Prophylactic
DJ
09/01IMMUTEP : Completes Recruitment, Dosing in Phase 2 Trial of Non-Small Cell Lung Cancer Com..
MT
08/31MERCK : Secures FDA Full Approval for Updated Indication for Keytruda to Treat Bladder Can..
MT
08/31MERCK : FDA Approves Updated Indication for Merck's KEYTRUDA« (pembrolizumab) for Treatmen..
BU
08/31Merck Announces Label Update for Keytruda, Merck’s Anti-PD-1 Therapy, for Its Indicatio..
CI
08/27OSE IMMUNOTHERAPEUTICS : Enrolls First Patient in Phase 2 Study of Ovarian Cancer Treatmen..
MT
08/26MERCK : Keytruda Wins Two New Japanese Approvals
MT
08/26MERCK : KEYTRUDA« (pembrolizumab) Receives Two New Approvals in Japan
BU
08/26Merck’s Keytruda (Pembrolizumab) Receives Two New Approvals in Japan
CI
08/25MERCK : Pneumococcal Vaccine Meets Safety Endpoints in Trial Reviewing Use in Infants
MT
08/25Warren Buffett's latest shopping spree
08/25MERCK : Announces VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) Met Key Im..
BU
08/25Merck & Co., Inc. Announces Topline Results from the Pivotal PNEU-PED (V114-029) Study
CI
08/25Merck's Vaxneuvance Hits Key Endpoints in Infant Study
DJ
08/23MERCK : Leslie A. Brun Resigns from Merck Board of Directors
AQ
08/23MERCK : WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson
AQ
08/20MERCK : Leslie A. Brun Resigns from Merck Board of Directors (Form 8-K)
PU
08/20Merck & Co., Inc. Announces Resignation of Leslie A. Brun as Board of Director
CI
08/20MERCK : Leslie A. Brun Resigns from Merck Board of Directors
BU
08/19ADAGENE : Joins Forces With Merck for Study of Cancer Treatment Candidate ADG106 in Combin..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on MERCK & CO., INC.